Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

22,034 public trials 3,765 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

NCT06075264

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +26 more
Locations
  • Florida Gynecologic Oncology Fort Myers, Florida, United States
  • Ascension St. Vincent Indianapolis, Indiana, United States
  • Cleveland Clinic Fairview Hospital Cleveland, Ohio, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Recruiting

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

NCT07120529

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Uniwersyteckie Centrum Onkologii, Uniwersytecki Szpital Kliniczny w Białymstoku Bialystok, Poland
  • Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of Silesia Katowice, Poland
  • Klinika Ginekologii, Świętokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakład Opieki Zdrowotnej Kielce, Poland
  • Oddział Ginekologii Onkologicznej z Pododdziałem Urologii, Opolskie Centrum Onkologii Opole, Poland
View Trial Details
Recruiting

Genetic Testing Decision Aid

NCT05470920

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mass General at North Shore Cancer Center Danvers, Massachusetts, United States
View Trial Details
Recruiting

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

NCT05135975

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +32 more
Locations
  • Children's Hospital of Alabama/UAB Birmingham, Alabama, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Hospital at Montefiore The Bronx, New York, United States
View Trial Details
Recruiting

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

NCT04016389

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • MD Anderson Cancer Centre Houston, Texas, United States
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • L'Hôtel-Dieu de Québec Québec, Quebec, Canada
View Trial Details

Related conditions